News|Articles|February 10, 2023
SCOPE 2023: What Do You See for the Industry This Year?
Author(s)Lisa Henderson
Hope Meely, chief clinical officer at Slope, dives into what she envisions the clinical trial sector to develop in 2023.
Advertisement
In an interview at the 2023 SCOPE conference with ACT Editor-in-Chief, Lisa Henderson, Hope Meely, chief clinical officer at Slope, discusses the industry outlook for the rest of the year, including more precision medicine trials, along with more personalized medicine.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Site Relationships and Payment Reliability, AI Adoption Without Governance Risk, and China's Biotech Innovation Rise
2
ACT Brief: AI in Invoice Processing, Botanical Medicines and FDA Pathways, and Connected Trial Finance Systems
3
Inspection Readiness Is Not a Pre-Inspection Activity, It's an Execution Design Condition
4
Navigating the Adoption of Biomarker-Informed Trial Enrollment Beyond Oncology
5